# Understanding Vaccination Uptake Amongst Gay, Bisexual and Other Men Who Have Sex with Men in UK Sexual Health Services: A Qualitative Interview Study

**Authors:** Tom May, Joanna M. Kesten, Hannah E. Family, Harriet Fisher, Adele Wolujewicz, Marta Checchi, Hamish Mohammed, David Leeman, Sema Mandal, Lucy Yardley, Jeremy Horwood, Clare Thomas

PMC · DOI: 10.3390/vaccines14020112 · Vaccines · 2026-01-24

## TL;DR

This study explores why some gay and bisexual men in the UK accept or avoid vaccines, finding that healthcare recommendations and convenience help, but system issues and low awareness hinder uptake.

## Contribution

The study identifies both individual and systemic barriers and facilitators to vaccine uptake among GBMSM using a qualitative approach and the COM-B model.

## Key findings

- Healthcare provider recommendations and convenient vaccine delivery during clinic visits are key facilitators for vaccination uptake.
- Low knowledge of viruses and their risks exists, but willingness to be vaccinated remains high.
- System-level barriers like complex vaccine schedules and inconsistent access to vaccination histories hinder uptake.

## Abstract

Background/Objectives: In England, gay, bisexual, and other men who have sex with men (GBMSM) are eligible for vaccination at NHS sexual health services, including human papillomavirus (HPV), hepatitis A virus (HAV), and hepatitis B virus (HBV) vaccines. However, current research shows limited understanding of the factors influencing vaccination uptake among GBMSM. This study aimed to examine the barriers and facilitators affecting the offer and uptake of these vaccination programmes. Methods: A qualitative interview study following the Person-Based Approach (a systematic method for developing and optimising health interventions) involving GBMSM and sexual health service staff from two regions of England. Purposive sampling aimed to include GBMSM with diverse backgrounds and engagement with sexual health services. Patient and public involvement shaped the study design and interview topic guides. The interviews were recorded, transcribed, and thematically analysed to identify barriers and facilitators which were interpreted using the COM-B model of behaviour change. Results: Twenty GBMSM and eleven staff took part. The findings showed that opportunistic delivery of HPV, HAV, and HBV vaccination within sexual health services is mostly acceptable and feasible for GBMSM and staff, while also highlighting areas for optimization. Despite low knowledge of these viruses and their associated risks, willingness to be vaccinated was high, with healthcare provider recommendations and the convenience of vaccine delivery during routine clinic visits acting as important facilitators. However, the reach of opportunistic models was limited, particularly for individuals underserved by sexual health services or disengaged from GBMSM social networks. System-level barriers such as complex vaccine schedules (particularly when multiple schedules are combined), inconsistent access to vaccination histories, and limited system-level follow-up processes (e.g., automated invites and reminders) were also found to act as obstacles to vaccination uptake and delivery. Conclusions: To improve equitable uptake, sexual health services should explore the feasibility of addressing both individual and structural barriers through additional strategies, including targeted and persuasive communication to increase knowledge, leveraging regular contact with GBMSM to promote uptake, and implementing enhanced approaches to support vaccination completion (e.g., automated prompts or reminders).

## Full-text entities

- **Diseases:** warts (MESH:D014860), cervical cancer (MESH:D002583), flu (MESH:D007251), gonorrhoea (MESH:D006069), injury to (MESH:D014947), anxiety (MESH:D001007), hepatitis C (MESH:D019698), HBV infection (MESH:D006509), HAV infection (MESH:D006525), cancer (MESH:D009369), COVID (MESH:D000086382), infection (MESH:D007239), COM-B (MESH:D001523), STDs (MESH:D012749), liver failure (MESH:D017093), fatigue (MESH:D005221), Hepatitis (MESH:D056486), post-COVID (MESH:D000094024), ill (MESH:D002908), HIV (MESH:D015658)
- **Species:** Hepatovirus A (no rank) [taxon 12092], Homo sapiens (human, species) [taxon 9606], Human papillomavirus (species) [taxon 10566], Hepatitis B virus (no rank) [taxon 10407], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945162/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12945162/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945162/full.md

---
Source: https://tomesphere.com/paper/PMC12945162